| Drug Name | Herceptin ( Trastuzumab) |
|---|---|
| Drug Class |
Antibiotic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Reminder of importance of cardiac monitoring guidance during trastuzumab therapy to reduce the frequency and severity of left ventricular dysfunction and congestive heart failure |
| safety communication |
|
| Dear Healthcare provider letter DHPC |
|